比利时弗兰德斯两个独立队列中系统性硬化症Goh算法评定间质性肺病的发病率、患病率及长期进展
该回顾性队列研究分析了比利时两个中心722例系统性硬化症(SSc)患者12年随访数据,采用简化Goh算法评定间质性肺病(ILD)。基线ILD患病率34%,随访期间发病率为20.3/1000人年(95%CI:14.5-27.8);基线ILD患者5年时60%出现肺功能进展。早期SSc亚组患病率6%、发病率5.8/1000人年(95%CI:1.2-17.0)。
要点
- SSc患者基线ILD患病率34%,随访发病率20.3/1000人年。
- 基线ILD患者5年时60%出现肺功能进展。
- 早期SSc亚组ILD患病率6%、发病率5.8/1000人年。
核心结论
- 局限型和弥漫型SSc患者均应监测ILD演变。
- 早期SSc亚组ILD患病率和发病率较低,可能为未来构建统一随访路径提供参考。
研究设计与样本
- 回顾性分析两个弗兰德斯队列(根特大学医院和鲁汶大学医院)连续SSc患者12年随访数据。
- 共722例患者(60%局限型、20%弥漫型、20%早期SSc)具有基线HRCT,中位随访39个月(IQR 12-80)。
- ILD按简化Goh算法分类。
主要发现
- 基线时243例评为ILD,随访期间39例新发,患病率34%、发病率20.3/1000人年(95%CI:14.5-27.8)。
- 基线ILD患者中60%在5年随访时出现肺功能进展。
- 早期SSc亚组基线8例评为ILD、随访期间3例新发,患病率6%、发病率5.8/1000人年(95%CI:1.2-17.0)。
关键数值与推荐
- ILD进展定义为FVC相对下降≥10%,或FVC相对下降5-10%且DLCO下降≥15%,或HRCT extent增加。
临床怎么用
- 局限型和弥漫型SSc患者均应监测ILD演变。
- 早期SSc患者ILD患病率和发病率较低,随访策略需结合未来统一路径决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The epidemiology of interstitial lung disease (ILD) in systemic sclerosis (SSc) in Belgium is unknown. In literature, its prevalence varies between 19% and 52% in limited/diffuse cutaneous SSc (LcSSc/DcSSc). However, its prevalence in "early" SSc (pre-clinically overt SSc without [yet] skin involvement), nor its incidence rate in SSc (LcSSc/DcSSc/"early" SSc) has ever been described. Against this background, we aimed to determine the prevalence/incidence (rate) and progression of ILD in SSc. METHODS: 12-year follow-up data of consecutive SSc patients, included in two Flemish cohorts (University Hospitals Ghent and Leuven), were retrospectively analysed. ILD was classified according to the simplified Goh algorithm. Progression of ILD was defined as a relative decline of FVC ≥10%, a combined relative decline of FVC 5-10% and DLCO ≥15%, or as an increase in HRCT extent. RESULTS: 722 patients (60% LcSSc/ 20% DcSSc/ 20% "early" SSc, median (IQR) follow-up 39 [12-80] months) had baseline HRCT. 243 were rated to have ILD at baseline and 39 during follow-up (prevalence of 34%/ incidence rate of 20.3/1000PY, 95%CI:14.5-27.8). Amongst those with baseline ILD, 60% had lung functional progression at five years of follow-up. In the "early" SSc subgroup, eight patients were rated to have ILD at baseline and three during follow-up (prevalence of 6%/ incidence rate of 5.8/1000 PY, 95%CI:1.2-17.0). CONCLUSION: Both LcSSc and DcSSc patients should be monitored for ILD evolution. The low prevalence and incidence of ILD in the "early" SSc subgroup may instruct future decisions on the construction of uniform patient follow-up pathways in "early" SSc.
引用
- Vandecasteele E, Melsens K, Vanhaecke A, et al. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study. Semin Arthritis Rheum. 2021. PMID: 34403812. doi:10.1016/j.semarthrit.2021.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。